Table 1.
Cross tabulation of adverse events with age, gender, systemic disease category, and individual systemic diseases
| Long-term adverse events | P-value | |
|---|---|---|
| Gender | ||
| Male (N = 150) | 21 (14.0%) | 0.410 |
| Female (N = 348) | 59 (17.0%) | |
| Age category (years) | ||
| <40 (N = 333) | 52 (15.6%) | 0.699 |
| ≥40 (N = 165) | 28 (17.0%) | |
| Systemic diseases | ||
| Yes (N = 162) | 52 (15.5%) | 0.607 |
| No ( = 336) | 28 (17.3%) | |
| BMI categories | ||
| Normal (N = 226) | 38 (16.8%) | 0.678 |
| Overweight/Obese (N = 272) | 42 (15.4%) | |
| Anemia | ||
| No (452) | 70 (15.5%) | 0.271 |
| Yes (N = 46) | 10 (21.7%) | |
| Diabetes mellitus | ||
| No (472) | 78 (16.5%) | 0.232 |
| Yes (N = 26) | 2 (7.7%) | |
| Allergy | ||
| No (473) | 77 (16.3%) | 0.570 |
| Yes (N = 25) | 3 (12.0%) | |
| Thyroid disorders | ||
| No (474) | 73 (15.4%) | 0.073 |
| Yes (N = 24) | 7 (29.2%) | |
| Hypertension | ||
| No (476) | 76 (16.0%) | 0.782 |
| Yes (N = 22) | 4 (18.2%) | |
| Asthma | ||
| No (483) | 80 (16.6%) | 0.085 |
| Yes (N = 15) | 0 (.0%) |